Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy

The association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin’s lymphomas (NHL) has been demonstrated by epidemiological studies, in particular in highly endemic geographical areas such as Italy, Japan, and southern parts of United States. In these countries, together with diffuse...

Full description

Saved in:
Bibliographic Details
Main Authors: Luca Arcaini, Michele Merli, Stefano Volpetti, Sara Rattotti, Manuel Gotti, Francesco Zaja
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/638185
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563377979785216
author Luca Arcaini
Michele Merli
Stefano Volpetti
Sara Rattotti
Manuel Gotti
Francesco Zaja
author_facet Luca Arcaini
Michele Merli
Stefano Volpetti
Sara Rattotti
Manuel Gotti
Francesco Zaja
author_sort Luca Arcaini
collection DOAJ
description The association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin’s lymphomas (NHL) has been demonstrated by epidemiological studies, in particular in highly endemic geographical areas such as Italy, Japan, and southern parts of United States. In these countries, together with diffuse large B-cell lymphomas, marginal zone lymphomas are the histotypes most frequently associated with HCV infection; in Italy around 20–30% cases of marginal zone lymphomas are HCV positive. Recently, antiviral treatment with interferon with or without ribavirin has been proved to be effective in the treatment of HCV-positive patients affected by indolent lymphoma, prevalently of marginal zone origin. An increasing number of experiences confirmed the validity of this approach in marginal zone lymphomas and in other indolent NHL subtypes like lymphoplasmacytic lymphoma. Across different studies, overall response rate was approximately 75%. Hematological responses resulted significantly associated with the eradication of the virus. This is the strongest evidence of a causative link between HCV and lymphomas. The aim of this paper is to illustrate the relationship between HCV infection and different subtypes of indolent B-cell lymphomas and to systematically summarize the data from the therapeutic studies that reported the use of antiviral treatment as hematological therapy in patients with HCV-associated indolent lymphomas.
format Article
id doaj-art-b34ea388ba034460b58af416fff1df93
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-b34ea388ba034460b58af416fff1df932025-02-03T01:20:26ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/638185638185Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral TherapyLuca Arcaini0Michele Merli1Stefano Volpetti2Sara Rattotti3Manuel Gotti4Francesco Zaja5Department of Hematology Oncology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyDivision of Hematology, Department of Internal Medicine, Ospedale di Circolo, Fondazione Macchi, 21100 Varese, ItalyDepartment of Hematology, DISM, Azienda Ospedaliero Universitaria S. M. Misericordia, 33100 Udine, ItalyDepartment of Hematology Oncology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyDepartment of Hematology Oncology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyDepartment of Hematology, DISM, Azienda Ospedaliero Universitaria S. M. Misericordia, 33100 Udine, ItalyThe association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin’s lymphomas (NHL) has been demonstrated by epidemiological studies, in particular in highly endemic geographical areas such as Italy, Japan, and southern parts of United States. In these countries, together with diffuse large B-cell lymphomas, marginal zone lymphomas are the histotypes most frequently associated with HCV infection; in Italy around 20–30% cases of marginal zone lymphomas are HCV positive. Recently, antiviral treatment with interferon with or without ribavirin has been proved to be effective in the treatment of HCV-positive patients affected by indolent lymphoma, prevalently of marginal zone origin. An increasing number of experiences confirmed the validity of this approach in marginal zone lymphomas and in other indolent NHL subtypes like lymphoplasmacytic lymphoma. Across different studies, overall response rate was approximately 75%. Hematological responses resulted significantly associated with the eradication of the virus. This is the strongest evidence of a causative link between HCV and lymphomas. The aim of this paper is to illustrate the relationship between HCV infection and different subtypes of indolent B-cell lymphomas and to systematically summarize the data from the therapeutic studies that reported the use of antiviral treatment as hematological therapy in patients with HCV-associated indolent lymphomas.http://dx.doi.org/10.1155/2012/638185
spellingShingle Luca Arcaini
Michele Merli
Stefano Volpetti
Sara Rattotti
Manuel Gotti
Francesco Zaja
Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
Clinical and Developmental Immunology
title Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
title_full Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
title_fullStr Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
title_full_unstemmed Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
title_short Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
title_sort indolent b cell lymphomas associated with hcv infection clinical and virological features and role of antiviral therapy
url http://dx.doi.org/10.1155/2012/638185
work_keys_str_mv AT lucaarcaini indolentbcelllymphomasassociatedwithhcvinfectionclinicalandvirologicalfeaturesandroleofantiviraltherapy
AT michelemerli indolentbcelllymphomasassociatedwithhcvinfectionclinicalandvirologicalfeaturesandroleofantiviraltherapy
AT stefanovolpetti indolentbcelllymphomasassociatedwithhcvinfectionclinicalandvirologicalfeaturesandroleofantiviraltherapy
AT sararattotti indolentbcelllymphomasassociatedwithhcvinfectionclinicalandvirologicalfeaturesandroleofantiviraltherapy
AT manuelgotti indolentbcelllymphomasassociatedwithhcvinfectionclinicalandvirologicalfeaturesandroleofantiviraltherapy
AT francescozaja indolentbcelllymphomasassociatedwithhcvinfectionclinicalandvirologicalfeaturesandroleofantiviraltherapy